Hematology TimesFDA investigating VTEs related to ECPFebruary 6, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Hematology TimesMogamulizumab is ‘valuable’ option for CTCLFebruary 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesIn situ vaccination eradicates lymphoma, other cancersFebruary 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo could treat double-hit lymphomaFebruary 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTechnique could aid treatment of CLLJanuary 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesEC authorizes brentuximab vedotin for CTCLJanuary 23, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesOfatumumab to be pulled from non-US marketsJanuary 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesRisks of MGUS persist beyond 30 yearsJanuary 18, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCAR T-cell therapy on fast track in US, EUJanuary 18, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesGeneric bortezomib available in USJanuary 13, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesSurvival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesMarine animals aid development of cytotoxicity assayJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesOvercoming resistance to ibrutinib in CLLJanuary 9, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDLBCL survivors at greater risk of autoimmune, infectious diseasesJanuary 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesUpdate reveals ongoing responses in ZUMA-1December 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
